Drug-eluting balloon: is it useful?

Area of Science:

• Cardiology
• Interventional Cardiology

Background:

• Coronary artery disease (CAD) is a growing global health concern.
• Coronary interventions, particularly stenting, are common treatments for CAD.
• Existing interventions face challenges including long-term effects and cost.

Purpose of the Study:

• To compare the efficacy and safety of balloon-based versus stent-based coronary interventions.
• To evaluate the emerging role of drug-eluting balloons (DEBs) in percutaneous coronary intervention (PCI).

Main Methods:

• Review of clinical trials comparing balloon angioplasty with stenting in CAD.
• Analysis of outcomes associated with drug-eluting balloons versus drug-eluting stents.
• Assessment of factors such as clinical outcomes, complications, cost, and technique complexity.

Main Results:

• Stent-based interventions, while prevalent, are associated with potential long-term adverse effects.
• Drug-eluting balloons demonstrate significant benefits not achievable with traditional stent therapy.
• PCI using DEBs shows advantages in clinical outcomes and complication profiles in specific patient groups.

Conclusions:

• Percutaneous coronary intervention (PCI) provides effective treatment for coronary artery disease compared to medical management.
• While stents (bare-metal and drug-eluting) are currently preferred, drug-eluting balloons are emerging as a favorable option.
• Recent clinical trials suggest drug-eluting balloons offer superior clinical outcomes and reduced complications in select PCI scenarios.